A University of Toronto team reported promising results from a trial of tiny injectable patches made from cardiac tissue.
Scientists at Yale University believe they’ve discovered how lysosomes—the "garbage disposal" units in brain cells—contribute to Alzheimer’s.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
An approved diabetes drug may change the progression of Parkinson's disease rather than just treating symptoms while the disease worsens.
Feinstein Institute-led researchers used an Alzheimer’s drug to reduce inflammation in people with metabolic syndrome.
Targeting a cell process that promotes protein clumping could lead to new drugs for ALS.
A pair of experimental vaccines protected mouse fetuses from brain defects caused by Zika infection.
Anti-CRISPR proteins may be the key to preventing harmful side effects from off-target editing.
Researchers at Washington University have discovered a new way to shield fetuses from Zika using a common and inexpensive malaria drug.
A team led by Washington University in St. Louis has unraveled the structure of a protein that allows RSV to elude the immune system.
A new finding by scientists at NYU may prompt fresh ideas for reversing the buildup of plaque in arteries.